Chien-Yu Lu
Overview
Explore the profile of Chien-Yu Lu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
1118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Tsai H, Huang C, Yeh Y, Ma C, Chen C, Lu C, et al.
BMC Surg
. 2016 Apr;
16:17.
PMID: 27079509
Background: To identify factors affecting the harvest of lymph nodes (LNs) and to investigate the association between examining a minimum of 12 LNs and clinical outcomes in stage I-III colorectal...
12.
Liu C, Kuo F, Wang C, Kuo C, Wang S, Chen C, et al.
J Cell Mol Med
. 2016 Mar;
20(5):962-72.
PMID: 26945908
Epidemiologic data show the incidence of gastric cancer in men is twofold higher than in women worldwide. Oestrogen is reported to have the capacity against gastric cancer development. Endogenous oestrogen...
13.
Yang I, Tsai H, Huang C, Lu C, Miao Z, Chang S, et al.
Oncotarget
. 2016 Mar;
7(14):18837-50.
PMID: 26934556
The high prevalence of type 2 diabetes mellitus in colorectal cancer patients is a crucial public health issue worldwide. The deregulation of microRNAs has been shown to be associated with...
14.
Yeh Y, Tsai H, Huang C, Wang J, Lin Y, Tang H, et al.
Trials
. 2016 Jan;
17:46.
PMID: 26811156
Background: Irinotecan is approved and widely administered to metastatic colorectal cancer (mCRC) patients; however, it can cause severe toxicities including neutropenia and diarrhea. The polymorphisms of genes encoding drug-metabolizing enzymes...
15.
Lu C, Huang C, Wu I, Tsai H, Ma C, Yeh Y, et al.
Transl Oncol
. 2015 Dec;
8(6):474-9.
PMID: 26692528
Purpose: This study aimed to identify the efficacy and toxicity of the FOLFIRI regimen (fluorouracil, leucovorin, and irinotecan) with irinotecan dose escalation plus bevacizumab as first-line chemotherapy for metastatic colorectal...
16.
17.
Lou Y, Chen C, Fan Y, Chang W, Lu C, Wu I, et al.
PLoS One
. 2015 Apr;
10(4):e0123973.
PMID: 25919688
Background: Methylation levels of long interspersed nucleotide elements (LINE-1) are representative of genome-wide methylation status and crucial in maintaining genomic stability and expression. Their prognostic impact on colon cancer patients...
18.
Ma C, Wu J, Tsai H, Huang C, Lu C, Sun L, et al.
Nutr J
. 2015 Jan;
14:9.
PMID: 25609264
Background: A lipid emulsion composed of soybean oil (long-chain triglycerides, LCT), medium-chain triglycerides (MCT) and n-3 poly-unsaturated fatty acids (PUFAs) was evaluated for immune-modulation efficacy, safety, and tolerance in patients...
19.
Wu M, Huang C, Kuo F, Hsu W, Wang S, Shih H, et al.
Biomed Res Int
. 2014 Dec;
2014:513725.
PMID: 25548772
Objective: This study was designed to compare the effect of Helicobacter pylori (H. pylori) infection treatment on serum zinc, copper, and selenium levels. Patients And Methods: We measured the serum...
20.
Lu C, Yeh Y, Huang C, Ma C, Yu F, Wang J
Onco Targets Ther
. 2014 Dec;
7:2143-6.
PMID: 25473295
Here we report a case of metastatic colon cancer treated with 5-fluorouracil, leucovorin, and escalated doses of irinotecan (FOLFIRI) combined with regorafenib in the fourth-line setting after uridine diphosphate glucuronosyltransferase...